Engineered Escherichia coli Nissle strains expressing human hormones improve microbial composition and alleviate metabolic dysfunction-associated steatotic liver disease (MASLD) in a mouse model: 16S amplicon sequencing

We proposed novel Engineered Escherichia coli Nissle strains expressing human hormones to alter the gut microbiota and alleviate metabolic dysfunction-associated steatotic liver disease (MASLD). By applying 16S sequencing, the engineered E.coli's effect on bacterial community and function was evaluated.